SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001513162-20-000129
Filing Date
2020-06-22
Accepted
2020-06-22 17:06:47
Documents
1
Period of Report
2020-06-22

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a.htm PRE 14A 491733
  Complete submission text file 0001513162-20-000129.txt   492914
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: PRE 14A | Act: 34 | File No.: 001-37492 | Film No.: 20979514
SIC: 2834 Pharmaceutical Preparations